Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 99 | 2025 | 2188 | 11.660 |
Why?
|
Substance-Related Disorders | 154 | 2024 | 4421 | 10.500 |
Why?
|
Buprenorphine | 39 | 2025 | 667 | 8.130 |
Why?
|
Opiate Substitution Treatment | 24 | 2025 | 452 | 4.790 |
Why?
|
Alcoholism | 53 | 2020 | 1980 | 4.500 |
Why?
|
Narcotic Antagonists | 29 | 2024 | 591 | 3.940 |
Why?
|
Analgesics, Opioid | 54 | 2024 | 3837 | 3.690 |
Why?
|
Naloxone | 18 | 2024 | 372 | 3.620 |
Why?
|
Cocaine-Related Disorders | 33 | 2020 | 458 | 3.540 |
Why?
|
Bipolar Disorder | 48 | 2019 | 5130 | 3.280 |
Why?
|
Cocaine | 31 | 2023 | 944 | 2.810 |
Why?
|
Psychotherapy | 21 | 2020 | 1648 | 2.110 |
Why?
|
Diagnosis, Dual (Psychiatry) | 39 | 2016 | 300 | 2.100 |
Why?
|
Psychotherapy, Group | 20 | 2021 | 417 | 2.000 |
Why?
|
Naltrexone | 12 | 2024 | 319 | 1.640 |
Why?
|
Anxiety Disorders | 17 | 2024 | 2743 | 1.510 |
Why?
|
Heroin Dependence | 9 | 2017 | 173 | 1.500 |
Why?
|
Substance Withdrawal Syndrome | 15 | 2018 | 627 | 1.480 |
Why?
|
Self-Help Groups | 10 | 2019 | 194 | 1.470 |
Why?
|
Alcohol-Related Disorders | 8 | 2016 | 243 | 1.430 |
Why?
|
Prescription Drugs | 10 | 2014 | 634 | 1.380 |
Why?
|
Counseling | 18 | 2021 | 1550 | 1.360 |
Why?
|
Behavior Therapy | 10 | 2024 | 886 | 1.340 |
Why?
|
Benzodiazepines | 8 | 2022 | 1137 | 1.280 |
Why?
|
Marijuana Abuse | 11 | 2020 | 409 | 1.280 |
Why?
|
Adult | 210 | 2025 | 223305 | 1.190 |
Why?
|
Cognition Disorders | 9 | 2012 | 3967 | 1.160 |
Why?
|
Substance Abuse Treatment Centers | 10 | 2014 | 155 | 1.150 |
Why?
|
Endocarditis | 3 | 2020 | 352 | 1.140 |
Why?
|
Substance Abuse Detection | 11 | 2014 | 301 | 1.140 |
Why?
|
Alcohol Deterrents | 7 | 2016 | 49 | 1.070 |
Why?
|
Humans | 326 | 2025 | 766812 | 0.990 |
Why?
|
Male | 222 | 2025 | 364154 | 0.960 |
Why?
|
Clinical Trials as Topic | 14 | 2023 | 8045 | 0.940 |
Why?
|
Sex Offenses | 3 | 2020 | 355 | 0.920 |
Why?
|
Female | 224 | 2025 | 396532 | 0.910 |
Why?
|
Stress Disorders, Post-Traumatic | 18 | 2021 | 4628 | 0.910 |
Why?
|
Patient Compliance | 10 | 2020 | 2694 | 0.870 |
Why?
|
Catastrophization | 4 | 2020 | 352 | 0.870 |
Why?
|
Cannabis | 3 | 2021 | 447 | 0.860 |
Why?
|
Affect | 7 | 2013 | 1494 | 0.850 |
Why?
|
Anxiety | 13 | 2025 | 4668 | 0.840 |
Why?
|
Research Design | 15 | 2024 | 6206 | 0.830 |
Why?
|
Psychiatric Status Rating Scales | 35 | 2016 | 6020 | 0.820 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 1086 | 0.820 |
Why?
|
Delayed-Action Preparations | 4 | 2024 | 966 | 0.780 |
Why?
|
Central Nervous System Stimulants | 4 | 2023 | 1168 | 0.760 |
Why?
|
Methamphetamine | 1 | 2023 | 167 | 0.760 |
Why?
|
Comorbidity | 42 | 2019 | 10580 | 0.750 |
Why?
|
Depressive Disorder | 15 | 2019 | 3715 | 0.750 |
Why?
|
Narcotics | 5 | 2013 | 332 | 0.740 |
Why?
|
Treatment Refusal | 2 | 2020 | 433 | 0.720 |
Why?
|
Pain | 14 | 2023 | 5098 | 0.710 |
Why?
|
Receptors, Opioid, mu | 2 | 2021 | 167 | 0.700 |
Why?
|
Behavior, Addictive | 5 | 2015 | 429 | 0.700 |
Why?
|
Unsafe Sex | 3 | 2013 | 239 | 0.700 |
Why?
|
Cues | 3 | 2016 | 877 | 0.700 |
Why?
|
Heroin | 6 | 2024 | 120 | 0.690 |
Why?
|
Motivation | 11 | 2022 | 2020 | 0.680 |
Why?
|
Personal Satisfaction | 2 | 2023 | 642 | 0.660 |
Why?
|
Societies, Scientific | 1 | 2020 | 221 | 0.650 |
Why?
|
Patient Acceptance of Health Care | 8 | 2015 | 3230 | 0.640 |
Why?
|
Substance Abuse, Intravenous | 3 | 2020 | 530 | 0.640 |
Why?
|
Community Mental Health Services | 3 | 2011 | 386 | 0.640 |
Why?
|
Models, Statistical | 4 | 2023 | 5092 | 0.630 |
Why?
|
Psychotropic Drugs | 7 | 2012 | 880 | 0.620 |
Why?
|
Cannabinoids | 1 | 2021 | 174 | 0.620 |
Why?
|
Treatment Outcome | 55 | 2025 | 65286 | 0.610 |
Why?
|
Middle Aged | 103 | 2025 | 223267 | 0.600 |
Why?
|
Mood Disorders | 11 | 2019 | 1127 | 0.600 |
Why?
|
Psychiatry | 3 | 2020 | 1715 | 0.590 |
Why?
|
Young Adult | 50 | 2024 | 59939 | 0.590 |
Why?
|
Self Report | 11 | 2024 | 3771 | 0.590 |
Why?
|
Tobacco Use Disorder | 7 | 2024 | 708 | 0.580 |
Why?
|
Psychometrics | 17 | 2023 | 3060 | 0.570 |
Why?
|
Combined Modality Therapy | 25 | 2017 | 8540 | 0.570 |
Why?
|
Oxycodone | 3 | 2022 | 144 | 0.550 |
Why?
|
Linear Models | 3 | 2023 | 5873 | 0.550 |
Why?
|
Legislation, Medical | 1 | 2017 | 99 | 0.540 |
Why?
|
Psychotic Disorders | 8 | 2022 | 3275 | 0.540 |
Why?
|
Taurine | 6 | 2016 | 91 | 0.530 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 97 | 0.530 |
Why?
|
Neuropsychological Tests | 10 | 2013 | 7119 | 0.520 |
Why?
|
Drug Prescriptions | 5 | 2022 | 1663 | 0.510 |
Why?
|
Ambulatory Care | 12 | 2023 | 2779 | 0.510 |
Why?
|
Irritable Mood | 1 | 2016 | 196 | 0.490 |
Why?
|
Mental Disorders | 17 | 2019 | 6869 | 0.490 |
Why?
|
Community Mental Health Centers | 2 | 2013 | 93 | 0.490 |
Why?
|
Self Medication | 5 | 2013 | 115 | 0.490 |
Why?
|
Child Abuse | 6 | 2020 | 1090 | 0.480 |
Why?
|
Smoking Cessation | 5 | 2016 | 2085 | 0.480 |
Why?
|
Pain Measurement | 7 | 2019 | 3576 | 0.470 |
Why?
|
Endpoint Determination | 1 | 2017 | 592 | 0.470 |
Why?
|
Social Support | 5 | 2011 | 2191 | 0.470 |
Why?
|
Urinalysis | 2 | 2014 | 369 | 0.470 |
Why?
|
Inpatients | 3 | 2023 | 2566 | 0.470 |
Why?
|
Longitudinal Studies | 17 | 2023 | 14762 | 0.460 |
Why?
|
Severity of Illness Index | 23 | 2019 | 15912 | 0.460 |
Why?
|
Secondary Prevention | 7 | 2023 | 1469 | 0.450 |
Why?
|
Patient Dropouts | 5 | 2020 | 411 | 0.440 |
Why?
|
Prevalence | 16 | 2023 | 15835 | 0.440 |
Why?
|
Methadone | 7 | 2023 | 317 | 0.440 |
Why?
|
Residential Treatment | 2 | 2011 | 112 | 0.430 |
Why?
|
Domestic Violence | 4 | 2009 | 180 | 0.430 |
Why?
|
Hospitalization | 20 | 2020 | 10816 | 0.430 |
Why?
|
Adolescent | 54 | 2024 | 88902 | 0.430 |
Why?
|
Restless Legs Syndrome | 1 | 2016 | 235 | 0.430 |
Why?
|
Follow-Up Studies | 28 | 2020 | 39312 | 0.430 |
Why?
|
Token Economy | 1 | 2013 | 17 | 0.430 |
Why?
|
Patient Discharge | 4 | 2020 | 3466 | 0.420 |
Why?
|
Pilot Projects | 13 | 2024 | 8728 | 0.420 |
Why?
|
Depression | 7 | 2019 | 8225 | 0.410 |
Why?
|
Social Adjustment | 2 | 2013 | 634 | 0.410 |
Why?
|
Alcoholics Anonymous | 5 | 2008 | 32 | 0.400 |
Why?
|
United States | 45 | 2024 | 72945 | 0.400 |
Why?
|
Disabled Persons | 1 | 2022 | 1209 | 0.390 |
Why?
|
Adaptation, Psychological | 6 | 2022 | 2662 | 0.380 |
Why?
|
Job Application | 1 | 2011 | 38 | 0.380 |
Why?
|
Nicotine | 4 | 2023 | 680 | 0.370 |
Why?
|
Chi-Square Distribution | 8 | 2023 | 3431 | 0.370 |
Why?
|
Personality Inventory | 6 | 2007 | 1019 | 0.360 |
Why?
|
Patient Care Management | 1 | 2014 | 302 | 0.360 |
Why?
|
Suicide | 1 | 2022 | 1606 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2020 | 10384 | 0.350 |
Why?
|
Public Policy | 1 | 2014 | 551 | 0.340 |
Why?
|
Risk-Taking | 3 | 2011 | 1022 | 0.340 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2012 | 197 | 0.340 |
Why?
|
Attitude to Health | 4 | 2016 | 2021 | 0.340 |
Why?
|
Outpatients | 6 | 2021 | 1596 | 0.340 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 11 | 2024 | 1988 | 0.320 |
Why?
|
Euphoria | 2 | 2008 | 64 | 0.320 |
Why?
|
Sex Factors | 15 | 2023 | 10619 | 0.320 |
Why?
|
Acupuncture Points | 1 | 2009 | 104 | 0.320 |
Why?
|
Temperance | 6 | 2015 | 88 | 0.310 |
Why?
|
Suicide, Attempted | 8 | 2019 | 1413 | 0.310 |
Why?
|
Patient Preference | 2 | 2016 | 946 | 0.300 |
Why?
|
Education | 1 | 2011 | 531 | 0.300 |
Why?
|
Cognition | 4 | 2023 | 7057 | 0.300 |
Why?
|
Affective Disorders, Psychotic | 1 | 2009 | 187 | 0.300 |
Why?
|
Recurrence | 16 | 2016 | 8507 | 0.290 |
Why?
|
Genetic Linkage | 6 | 2010 | 2342 | 0.290 |
Why?
|
Alcohol Drinking | 5 | 2016 | 4045 | 0.290 |
Why?
|
Reproducibility of Results | 17 | 2023 | 20146 | 0.290 |
Why?
|
Disulfiram | 2 | 2020 | 63 | 0.290 |
Why?
|
National Institute on Drug Abuse (U.S.) | 6 | 2014 | 11 | 0.290 |
Why?
|
Cross-Sectional Studies | 20 | 2023 | 26309 | 0.280 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2009 | 169 | 0.280 |
Why?
|
Withholding Treatment | 2 | 2024 | 619 | 0.280 |
Why?
|
Feasibility Studies | 7 | 2024 | 5306 | 0.280 |
Why?
|
Paranoid Disorders | 5 | 2011 | 61 | 0.280 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2018 | 1104 | 0.270 |
Why?
|
Risk | 4 | 2016 | 9602 | 0.270 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 273 | 0.270 |
Why?
|
Hypnotics and Sedatives | 4 | 2018 | 1193 | 0.270 |
Why?
|
Antipsychotic Agents | 5 | 2011 | 3078 | 0.260 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2009 | 69 | 0.260 |
Why?
|
Deception | 1 | 2007 | 99 | 0.260 |
Why?
|
Sex Characteristics | 3 | 2020 | 2645 | 0.260 |
Why?
|
Adolescent Behavior | 3 | 2014 | 1185 | 0.260 |
Why?
|
Ecosystem | 1 | 2010 | 490 | 0.260 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1463 | 0.260 |
Why?
|
Interview, Psychological | 6 | 2011 | 810 | 0.250 |
Why?
|
Administration, Sublingual | 2 | 2024 | 60 | 0.250 |
Why?
|
Executive Function | 5 | 2013 | 1396 | 0.250 |
Why?
|
Self Efficacy | 2 | 2019 | 643 | 0.250 |
Why?
|
Anti-Anxiety Agents | 3 | 2018 | 404 | 0.250 |
Why?
|
Drug Therapy | 2 | 2005 | 504 | 0.250 |
Why?
|
Employment | 2 | 2011 | 1110 | 0.240 |
Why?
|
Massachusetts | 13 | 2020 | 8890 | 0.240 |
Why?
|
Sexual Behavior | 2 | 2011 | 2193 | 0.230 |
Why?
|
Likelihood Functions | 2 | 2023 | 993 | 0.230 |
Why?
|
Medication Adherence | 3 | 2011 | 2190 | 0.230 |
Why?
|
Multicenter Studies as Topic | 3 | 2018 | 1733 | 0.230 |
Why?
|
Information Services | 1 | 2005 | 239 | 0.220 |
Why?
|
Lithium | 2 | 1998 | 599 | 0.220 |
Why?
|
Attention | 6 | 2013 | 2413 | 0.220 |
Why?
|
Patient Selection | 5 | 2011 | 4252 | 0.220 |
Why?
|
Drug Therapy, Combination | 6 | 2016 | 6306 | 0.220 |
Why?
|
Borderline Personality Disorder | 1 | 2010 | 767 | 0.210 |
Why?
|
Primary Health Care | 7 | 2022 | 4735 | 0.210 |
Why?
|
Antidepressive Agents | 2 | 2012 | 2903 | 0.210 |
Why?
|
Hallucinogens | 2 | 2009 | 212 | 0.210 |
Why?
|
Mass Screening | 6 | 2023 | 5454 | 0.200 |
Why?
|
Memory | 5 | 2013 | 2192 | 0.200 |
Why?
|
Hydrocodone | 1 | 2022 | 48 | 0.200 |
Why?
|
Patient Satisfaction | 3 | 2024 | 3485 | 0.200 |
Why?
|
District of Columbia | 1 | 2022 | 159 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4056 | 0.190 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 6 | 2010 | 3724 | 0.190 |
Why?
|
Quality Assurance, Health Care | 2 | 2011 | 2171 | 0.190 |
Why?
|
Quality of Life | 8 | 2023 | 13476 | 0.190 |
Why?
|
Achievement | 1 | 2003 | 287 | 0.190 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7870 | 0.190 |
Why?
|
Stress, Psychological | 2 | 2017 | 4526 | 0.190 |
Why?
|
Pregnancy Complications | 2 | 2015 | 2971 | 0.190 |
Why?
|
Life Change Events | 4 | 2009 | 956 | 0.190 |
Why?
|
Patient Education as Topic | 4 | 2024 | 2334 | 0.190 |
Why?
|
Hospitals, Psychiatric | 6 | 2017 | 317 | 0.180 |
Why?
|
Risk Factors | 23 | 2022 | 74889 | 0.180 |
Why?
|
Mental Health Services | 5 | 2019 | 1728 | 0.180 |
Why?
|
Remission, Spontaneous | 2 | 2012 | 384 | 0.180 |
Why?
|
Receptors, Serotonin | 1 | 2001 | 210 | 0.180 |
Why?
|
Patient Admission | 5 | 2008 | 1364 | 0.180 |
Why?
|
Pyridines | 1 | 2012 | 2888 | 0.180 |
Why?
|
Health Status | 6 | 2015 | 4087 | 0.180 |
Why?
|
Drug Users | 2 | 2020 | 134 | 0.180 |
Why?
|
Multivariate Analysis | 6 | 2013 | 12064 | 0.170 |
Why?
|
Time Factors | 11 | 2019 | 40149 | 0.170 |
Why?
|
Computer Simulation | 3 | 2023 | 6258 | 0.170 |
Why?
|
Socioeconomic Factors | 8 | 2015 | 7841 | 0.170 |
Why?
|
Self-Injurious Behavior | 1 | 2006 | 571 | 0.170 |
Why?
|
Normal Distribution | 1 | 2020 | 267 | 0.170 |
Why?
|
Drive | 1 | 2019 | 34 | 0.170 |
Why?
|
Referral and Consultation | 4 | 2015 | 3618 | 0.170 |
Why?
|
Crime | 3 | 2018 | 206 | 0.170 |
Why?
|
Comprehension | 1 | 2005 | 638 | 0.170 |
Why?
|
Quality of Health Care | 2 | 2005 | 4306 | 0.170 |
Why?
|
Personality Disorders | 2 | 1995 | 727 | 0.170 |
Why?
|
Seizures | 1 | 2012 | 2996 | 0.160 |
Why?
|
Prognosis | 13 | 2019 | 29959 | 0.160 |
Why?
|
Aged | 23 | 2022 | 171344 | 0.160 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3927 | 0.160 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2010 | 275 | 0.150 |
Why?
|
Photic Stimulation | 2 | 2016 | 1989 | 0.150 |
Why?
|
Pain Threshold | 2 | 2016 | 606 | 0.150 |
Why?
|
Ethanol | 4 | 2023 | 1326 | 0.150 |
Why?
|
Odds Ratio | 4 | 2020 | 9661 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2013 | 6214 | 0.150 |
Why?
|
Perception | 1 | 2004 | 1204 | 0.140 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2694 | 0.140 |
Why?
|
Factor Analysis, Statistical | 4 | 2021 | 1001 | 0.140 |
Why?
|
Nursing Care | 1 | 2017 | 66 | 0.140 |
Why?
|
Risperidone | 1 | 1999 | 383 | 0.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2017 | 7430 | 0.140 |
Why?
|
Spiritual Therapies | 1 | 2017 | 60 | 0.140 |
Why?
|
Logistic Models | 6 | 2020 | 13276 | 0.140 |
Why?
|
Injections | 1 | 2020 | 839 | 0.140 |
Why?
|
Case Management | 2 | 2019 | 276 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2020 | 301 | 0.130 |
Why?
|
Electronic Prescribing | 1 | 2017 | 115 | 0.130 |
Why?
|
Medication Therapy Management | 1 | 2017 | 131 | 0.130 |
Why?
|
Long-Term Care | 2 | 2017 | 630 | 0.130 |
Why?
|
HIV Infections | 4 | 2013 | 17532 | 0.130 |
Why?
|
Patient Participation | 1 | 2005 | 1445 | 0.130 |
Why?
|
Prospective Studies | 11 | 2017 | 54872 | 0.120 |
Why?
|
Prejudice | 1 | 2019 | 568 | 0.120 |
Why?
|
Methylphenidate | 2 | 2010 | 480 | 0.120 |
Why?
|
Valproic Acid | 1 | 1998 | 444 | 0.120 |
Why?
|
Predictive Value of Tests | 7 | 2012 | 15425 | 0.120 |
Why?
|
Age Factors | 8 | 2019 | 18397 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 1 | 2019 | 706 | 0.120 |
Why?
|
Smoking | 5 | 2020 | 9077 | 0.120 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 1987 | 93 | 0.120 |
Why?
|
Intelligence | 2 | 2011 | 925 | 0.120 |
Why?
|
Universities | 1 | 2019 | 1004 | 0.110 |
Why?
|
Telemedicine | 2 | 2022 | 3111 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1574 | 0.110 |
Why?
|
Health Surveys | 3 | 2016 | 4055 | 0.110 |
Why?
|
Religion | 1 | 2017 | 376 | 0.110 |
Why?
|
Amphetamine-Related Disorders | 1 | 2014 | 80 | 0.110 |
Why?
|
Fructose | 1 | 2016 | 284 | 0.110 |
Why?
|
Data Collection | 3 | 2013 | 3321 | 0.110 |
Why?
|
Professional-Patient Relations | 2 | 2001 | 724 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2013 | 935 | 0.110 |
Why?
|
Retrospective Studies | 15 | 2023 | 81657 | 0.110 |
Why?
|
Corpus Striatum | 1 | 2019 | 1218 | 0.110 |
Why?
|
Psychological Tests | 4 | 2007 | 642 | 0.110 |
Why?
|
Antimanic Agents | 2 | 2009 | 523 | 0.110 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 299 | 0.110 |
Why?
|
Regression Analysis | 5 | 2013 | 6329 | 0.110 |
Why?
|
Acetylcysteine | 1 | 2014 | 262 | 0.110 |
Why?
|
Memory, Short-Term | 2 | 2011 | 1004 | 0.100 |
Why?
|
Self Concept | 2 | 2018 | 1040 | 0.100 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1467 | 0.100 |
Why?
|
Anticonvulsants | 2 | 2018 | 1921 | 0.100 |
Why?
|
Dreams | 1 | 2014 | 145 | 0.100 |
Why?
|
Diagnosis, Differential | 5 | 2012 | 12985 | 0.100 |
Why?
|
Survivors | 2 | 2022 | 2379 | 0.100 |
Why?
|
Schizophrenia | 3 | 2007 | 6976 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2764 | 0.100 |
Why?
|
Therapeutic Community | 1 | 2011 | 19 | 0.100 |
Why?
|
Catechol O-Methyltransferase | 2 | 2011 | 250 | 0.100 |
Why?
|
Sexual Partners | 2 | 2009 | 804 | 0.100 |
Why?
|
Community Health Services | 3 | 2011 | 659 | 0.100 |
Why?
|
Prolactin | 1 | 1994 | 628 | 0.100 |
Why?
|
Desipramine | 2 | 1989 | 182 | 0.100 |
Why?
|
Haplotypes | 5 | 2011 | 2726 | 0.090 |
Why?
|
Statistics as Topic | 2 | 2008 | 2350 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2011 | 16044 | 0.090 |
Why?
|
Chronic Disease | 5 | 2009 | 9358 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 823 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10745 | 0.090 |
Why?
|
Confidence Intervals | 2 | 2009 | 2921 | 0.090 |
Why?
|
Depressive Disorder, Major | 4 | 2019 | 4810 | 0.090 |
Why?
|
Gene Frequency | 8 | 2010 | 3624 | 0.090 |
Why?
|
Manuals as Topic | 3 | 2000 | 99 | 0.090 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 13 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4853 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2021 | 2425 | 0.090 |
Why?
|
Reading | 1 | 2014 | 541 | 0.090 |
Why?
|
Biomedical Research | 2 | 2020 | 3459 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3717 | 0.080 |
Why?
|
Milieu Therapy | 1 | 1989 | 3 | 0.080 |
Why?
|
Mannosidases | 1 | 2009 | 21 | 0.080 |
Why?
|
Vermont | 1 | 2009 | 80 | 0.080 |
Why?
|
Gender Identity | 1 | 2015 | 767 | 0.080 |
Why?
|
Personality Assessment | 4 | 2006 | 646 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1673 | 0.080 |
Why?
|
Guideline Adherence | 2 | 2017 | 2233 | 0.080 |
Why?
|
New Hampshire | 1 | 2009 | 174 | 0.080 |
Why?
|
Negativism | 1 | 2008 | 23 | 0.080 |
Why?
|
Cyclothymic Disorder | 2 | 2004 | 42 | 0.080 |
Why?
|
Pro-Opiomelanocortin | 1 | 2009 | 139 | 0.080 |
Why?
|
Fentanyl | 2 | 2024 | 451 | 0.080 |
Why?
|
Goals | 3 | 2009 | 717 | 0.080 |
Why?
|
Directive Counseling | 1 | 2010 | 171 | 0.080 |
Why?
|
Psychology | 1 | 2010 | 353 | 0.080 |
Why?
|
Aftercare | 2 | 2008 | 915 | 0.080 |
Why?
|
Carbon Monoxide | 2 | 2013 | 560 | 0.080 |
Why?
|
Health Literacy | 1 | 2014 | 466 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2022 | 12536 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 326 | 0.070 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2008 | 137 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 8 | 2011 | 18076 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5513 | 0.070 |
Why?
|
Mental Health | 3 | 2024 | 3269 | 0.070 |
Why?
|
Chromosome Mapping | 4 | 2010 | 4618 | 0.070 |
Why?
|
Length of Stay | 4 | 2008 | 6491 | 0.070 |
Why?
|
Triage | 1 | 2014 | 995 | 0.070 |
Why?
|
Social Work | 1 | 2009 | 158 | 0.070 |
Why?
|
Adolescent Development | 1 | 2010 | 273 | 0.070 |
Why?
|
Placebo Effect | 2 | 2008 | 515 | 0.070 |
Why?
|
Carbamazepine | 2 | 2018 | 224 | 0.070 |
Why?
|
Medical Assistance | 1 | 2008 | 108 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1989 | 427 | 0.070 |
Why?
|
Self-Assessment | 2 | 2000 | 400 | 0.070 |
Why?
|
Receptors, GABA-A | 1 | 2011 | 624 | 0.070 |
Why?
|
Patient Care Team | 3 | 1995 | 2519 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1512 | 0.070 |
Why?
|
Dopa Decarboxylase | 1 | 2006 | 14 | 0.070 |
Why?
|
Veterans | 1 | 2020 | 2667 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14653 | 0.070 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.070 |
Why?
|
Nuclear Family | 4 | 2008 | 311 | 0.070 |
Why?
|
Child Abuse, Sexual | 3 | 1998 | 398 | 0.070 |
Why?
|
Social Behavior | 1 | 2013 | 1147 | 0.070 |
Why?
|
Genetic Variation | 4 | 2011 | 6613 | 0.060 |
Why?
|
Michigan | 1 | 2007 | 329 | 0.060 |
Why?
|
Patient Care Planning | 2 | 2008 | 904 | 0.060 |
Why?
|
Genotype | 9 | 2011 | 13036 | 0.060 |
Why?
|
Problem Solving | 1 | 2008 | 442 | 0.060 |
Why?
|
False Negative Reactions | 1 | 2007 | 570 | 0.060 |
Why?
|
Siblings | 2 | 2009 | 828 | 0.060 |
Why?
|
Cluster Analysis | 5 | 2008 | 2721 | 0.060 |
Why?
|
Pemoline | 1 | 1985 | 18 | 0.060 |
Why?
|
Antisocial Personality Disorder | 5 | 1997 | 224 | 0.060 |
Why?
|
Impulsive Behavior | 1 | 2008 | 345 | 0.060 |
Why?
|
Legislation, Drug | 1 | 2007 | 216 | 0.060 |
Why?
|
Double-Blind Method | 5 | 2016 | 12430 | 0.060 |
Why?
|
Child | 11 | 2024 | 80670 | 0.060 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2006 | 386 | 0.060 |
Why?
|
Terminology as Topic | 2 | 2013 | 1540 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 418 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1065 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2006 | 471 | 0.060 |
Why?
|
Medical Records | 2 | 2012 | 1408 | 0.060 |
Why?
|
Demography | 2 | 2006 | 1641 | 0.060 |
Why?
|
Pregnancy | 3 | 2015 | 30236 | 0.060 |
Why?
|
Genome, Human | 2 | 2008 | 4443 | 0.050 |
Why?
|
Probability | 2 | 2023 | 2476 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2011 | 2741 | 0.050 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 1996 | 0.050 |
Why?
|
Immunoassay | 1 | 2007 | 744 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2010 | 1828 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2005 | 3692 | 0.050 |
Why?
|
Administration, Cutaneous | 2 | 2013 | 712 | 0.050 |
Why?
|
Sick Role | 1 | 2003 | 229 | 0.050 |
Why?
|
Negotiating | 1 | 2003 | 152 | 0.050 |
Why?
|
Central Nervous System Depressants | 3 | 1988 | 163 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41706 | 0.050 |
Why?
|
Medicaid | 3 | 2024 | 2836 | 0.050 |
Why?
|
Oregon | 1 | 2022 | 148 | 0.050 |
Why?
|
Malignant Hyperthermia | 1 | 2001 | 72 | 0.050 |
Why?
|
ROC Curve | 1 | 2009 | 3621 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2008 | 2133 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3208 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8734 | 0.050 |
Why?
|
Survival Analysis | 3 | 2009 | 10101 | 0.050 |
Why?
|
Nitrosamines | 1 | 2021 | 86 | 0.050 |
Why?
|
Drug Interactions | 1 | 2005 | 1419 | 0.040 |
Why?
|
Anabolic Agents | 1 | 2003 | 256 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2007 | 1394 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6514 | 0.040 |
Why?
|
Age of Onset | 4 | 2009 | 3343 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 388 | 0.040 |
Why?
|
Waiting Lists | 1 | 2024 | 779 | 0.040 |
Why?
|
Disease Progression | 2 | 2019 | 13642 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2003 | 541 | 0.040 |
Why?
|
Sex Reassignment Procedures | 1 | 2019 | 72 | 0.040 |
Why?
|
Crack Cocaine | 1 | 1998 | 33 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 892 | 0.040 |
Why?
|
Acetaminophen | 1 | 2022 | 549 | 0.040 |
Why?
|
Bulimia | 2 | 1992 | 405 | 0.040 |
Why?
|
Social Environment | 2 | 2009 | 1012 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5536 | 0.040 |
Why?
|
Hospitals, Private | 1 | 2017 | 67 | 0.040 |
Why?
|
Population Surveillance | 1 | 2007 | 2594 | 0.030 |
Why?
|
Urban Population | 2 | 2019 | 2040 | 0.030 |
Why?
|
Disease | 1 | 2002 | 675 | 0.030 |
Why?
|
Risk Assessment | 4 | 2014 | 24299 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2004 | 1432 | 0.030 |
Why?
|
Parents | 1 | 2010 | 3592 | 0.030 |
Why?
|
Patient Readmission | 2 | 2004 | 3283 | 0.030 |
Why?
|
Pedigree | 4 | 2008 | 4539 | 0.030 |
Why?
|
Rehabilitation, Vocational | 1 | 1996 | 70 | 0.030 |
Why?
|
Self Care | 2 | 1999 | 800 | 0.030 |
Why?
|
Lod Score | 2 | 2006 | 600 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2510 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2020 | 937 | 0.030 |
Why?
|
Psychophysics | 1 | 2016 | 292 | 0.030 |
Why?
|
Aging | 1 | 2014 | 8728 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2006 | 3266 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2262 | 0.030 |
Why?
|
Pain Perception | 1 | 2016 | 197 | 0.030 |
Why?
|
Physicians | 1 | 2012 | 4591 | 0.030 |
Why?
|
Age Distribution | 1 | 2000 | 2869 | 0.030 |
Why?
|
Acyltransferases | 1 | 1996 | 305 | 0.030 |
Why?
|
Drug Combinations | 2 | 2010 | 2085 | 0.030 |
Why?
|
Lung Volume Measurements | 2 | 1987 | 381 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2846 | 0.030 |
Why?
|
Brain | 3 | 2010 | 27158 | 0.030 |
Why?
|
Cotinine | 1 | 2013 | 206 | 0.030 |
Why?
|
Accidents | 1 | 2013 | 164 | 0.020 |
Why?
|
Internship and Residency | 1 | 2012 | 5943 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1995 | 913 | 0.020 |
Why?
|
Alleles | 3 | 2009 | 6896 | 0.020 |
Why?
|
Hyperalgesia | 1 | 2016 | 527 | 0.020 |
Why?
|
Health Policy | 1 | 2004 | 2697 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2011 | 22248 | 0.020 |
Why?
|
Phenotype | 5 | 2007 | 16722 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 627 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2013 | 497 | 0.020 |
Why?
|
Risk Management | 1 | 2013 | 558 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4858 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 956 | 0.020 |
Why?
|
Phencyclidine Abuse | 1 | 1988 | 8 | 0.020 |
Why?
|
National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2008 | 10 | 0.020 |
Why?
|
Population | 1 | 2009 | 140 | 0.020 |
Why?
|
Norepinephrine | 1 | 2011 | 898 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 1991 | 550 | 0.020 |
Why?
|
Penetrance | 1 | 2010 | 388 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1988 | 355 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2009 | 313 | 0.020 |
Why?
|
Leukocytes | 1 | 1996 | 2034 | 0.020 |
Why?
|
Algorithms | 2 | 2005 | 14073 | 0.020 |
Why?
|
Family | 2 | 2009 | 3209 | 0.020 |
Why?
|
Amphetamine | 1 | 1988 | 222 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3564 | 0.020 |
Why?
|
Child of Impaired Parents | 1 | 1991 | 462 | 0.020 |
Why?
|
Family Relations | 1 | 2009 | 318 | 0.020 |
Why?
|
Medication Errors | 1 | 2013 | 784 | 0.020 |
Why?
|
Utilization Review | 1 | 2008 | 381 | 0.020 |
Why?
|
Narcissism | 1 | 1986 | 59 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8352 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2006 | 265 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9407 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 322 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 412 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1775 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 2 | 1999 | 792 | 0.010 |
Why?
|
Agoraphobia | 1 | 2004 | 177 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1659 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6853 | 0.010 |
Why?
|
Dopamine | 1 | 2011 | 1581 | 0.010 |
Why?
|
Cost Allocation | 1 | 2003 | 48 | 0.010 |
Why?
|
Language | 1 | 2013 | 1550 | 0.010 |
Why?
|
Introns | 1 | 2006 | 966 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 663 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 784 | 0.010 |
Why?
|
Arousal | 1 | 1989 | 1174 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 1992 | 1328 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2603 | 0.010 |
Why?
|
Mental Recall | 1 | 1989 | 1218 | 0.010 |
Why?
|
Syndrome | 1 | 1988 | 3271 | 0.010 |
Why?
|
Amygdala | 1 | 2010 | 1375 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4019 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1936 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1326 | 0.010 |
Why?
|
Genetic Testing | 1 | 2014 | 3591 | 0.010 |
Why?
|
Panic Disorder | 1 | 2004 | 613 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.010 |
Why?
|
Psychotherapeutic Processes | 1 | 2001 | 50 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1254 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6066 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 2007 | 1647 | 0.010 |
Why?
|
Neural Pathways | 1 | 2010 | 3079 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4249 | 0.010 |
Why?
|
Students | 1 | 2009 | 1741 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2783 | 0.010 |
Why?
|
Nerve Net | 1 | 2010 | 2307 | 0.010 |
Why?
|
Aggression | 1 | 2003 | 748 | 0.010 |
Why?
|
Oxygen | 2 | 1998 | 4252 | 0.010 |
Why?
|
DNA | 1 | 2011 | 7210 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4780 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2005 | 2353 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2394 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1981 | 1138 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7585 | 0.010 |
Why?
|
Animals | 1 | 2007 | 168939 | 0.010 |
Why?
|
Models, Genetic | 1 | 2005 | 3446 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1998 | 1006 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1996 | 313 | 0.010 |
Why?
|
Basal Ganglia | 1 | 1998 | 549 | 0.010 |
Why?
|
Combat Disorders | 1 | 1997 | 300 | 0.010 |
Why?
|
Internal-External Control | 1 | 1996 | 348 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1998 | 1478 | 0.010 |
Why?
|
Recovery of Function | 1 | 2003 | 2978 | 0.010 |
Why?
|
Electroencephalography | 1 | 1989 | 6282 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1998 | 860 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 36570 | 0.010 |
Why?
|
Incidence | 2 | 2006 | 21527 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1997 | 1438 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 1998 | 1118 | 0.010 |
Why?
|
Health Personnel | 1 | 2005 | 3384 | 0.010 |
Why?
|
Health Expenditures | 1 | 2003 | 2389 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1992 | 507 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12808 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1996 | 3587 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1998 | 1716 | 0.010 |
Why?
|
Marriage | 1 | 1992 | 351 | 0.010 |
Why?
|
Personality Tests | 1 | 1989 | 80 | 0.000 |
Why?
|
Reference Values | 1 | 1996 | 4914 | 0.000 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1988 | 93 | 0.000 |
Why?
|
Fatty Acids | 1 | 1996 | 1806 | 0.000 |
Why?
|
Monoamine Oxidase | 1 | 1988 | 179 | 0.000 |
Why?
|
Prefrontal Cortex | 1 | 1998 | 2224 | 0.000 |
Why?
|
Evoked Potentials, Auditory | 1 | 1989 | 529 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42577 | 0.000 |
Why?
|
Job Satisfaction | 1 | 1989 | 548 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2009 | 59548 | 0.000 |
Why?
|
Reaction Time | 1 | 1989 | 2085 | 0.000 |
Why?
|
Blood Platelets | 1 | 1988 | 2465 | 0.000 |
Why?
|